Muna Therapeutics

Next week, Elizabeth Birch, Muna’s Head of BD, will be connecting with colleagues from across the life sciences community at #BIO2025 — discussing our soon-to-be clinical stage programs, and how we are working to deliver better outcomes for patients by harnessing the power of the immune system to address neurodegenerative and inflammatory diseases. Learn more about Muna’s mission at munatherapeutics.com   #BIO2025 #Neuroscience #BrainResilience #Neurodegeneration

Alzheimer’s & Brain Awareness Month is a reminder of the urgent, unmet needs faced by millions of patients and families around the world. More than 200 million people are affected by neurodegenerative diseases globally– a number that continues to rise. At Muna, we’re focused on one goal: delivering a cure. Our all-in-human target discovery and validation approach, called MiND-MAP, leverages the biology of brain resilience to develop therapies designed to prevent, slow, or reverse neurodegenerative diseases like #Alzheimers. This month, as our colleagues ride to raise funds for Alzheimer’s research, we continue our work in the lab and clinic—driven by science, powered by purpose. Learn more and support Muna teammates riding in June’s 'Lucien Van Impe Classic’ for a cure: https://lnkd.in/eaepeDhP Learn more about Muna and our mission at munatherapeutics.com #BrainAwarenessMonth #AlzheimersAwareness #Neuroscience #BrainResilience

This June, members of our team will combine their personal passion with our professional purpose as they cycle 145km as part of the ‘Lucien Van Impe Classic’ – raising funds for Alzheimer’s research with Stichting Alzheimer Onderzoek / Fondation Recherche Alzheimer. At Muna, we’re dedicated to harnessing brain resilience to develop transformative therapies for patients affected by neurodegenerative diseases. By participating in this ride, our team is not only raising money, but also awareness of the urgent need for new therapeutic solutions for patients, caregivers, and families. We’re proud to be turning fun into funds—and we invite you to join us in supporting this vital cause: https://lnkd.in/eaepeDhP Learn more about Muna and our mission at munatherapeutics.com #BrainResilience #AlzheimersAwareness #CyclingForACure

This June, members of our team will combine their personal passion with our professional purpose as they cycle 145km as part of the ‘Lucien Van Impe Classic’ – raising funds for Alzheimer’s research with Stichting Alzheimer Onderzoek / Fondation Recherche Alzheimer. At Muna, we’re dedicated to harnessing brain resilience to develop transformative therapies for patients affected by neurodegenerative diseases. By participating in this ride, our team is not only raising money, but also awareness of the urgent need for new therapeutic solutions for patients, caregivers, and families. We’re proud to be turning fun into funds—and we invite you to join us in supporting this vital cause: https://lnkd.in/eaepeDhP Learn more about Muna and our mission at munatherapeutics.com #BrainResilience #AlzheimersAwareness #CyclingForACure

This week, Jonathan van Eyll is heading to Luxembourg to attend the 8th Venusberg Meeting on Neuroinflammation, organized by University of Luxembourg and Luxembourg Centre for Systems Biomedicine (LCSB) - University of Luxembourg. We look forward to engaging with our international peers and exploring emerging perspectives surrounding cerebral immune activation at the crossroads of healthy aging, senescence and neurodegeneration, all of which are vital for informing our efforts to harness brain resilience within our platforms as we advance toward the clinic. Learn more about our approach: munatherapeutics.com #alzheimers #parkinsons #trem2 #microglia

Our all-in-human MiND-MAP approach critically depends on brain donations and the organizations that curate them. Using single-cell spatial multi-omics and bioinformatics, our team analyzes human brain tissue samples to explore the key mechanisms of resilience to disease pathology and identify potential therapeutic targets. These samples enhance our understanding of what distinguishes healthy, resilient brains from those affected by neurodegenerative diseases. Importantly, studying human tissue also helps to address the limitations of animal models—such as species-specific differences that often hinder the translatability of findings to human biology—thereby accelerating the discovery and development of potential cures for conditions like #Alzheimers and #Parkinsons disease. This Brain Donation Awareness Day, we extend our sincere gratitude to all who donate brains for scientific research, as well as the brain centers we work with whose foundational work is invaluable: ●     Netherlands Brain Bank, Netherlands Institute for Neuroscience ●     BioRepository and Integrated Neuropathology (BRaIN) Laboratory, University of Washington ●     Oxford Brain Bank, University of Oxford ●     South West Dementia Brain Bank, University of Bristol To learn more about Muna's innovative approach to neurodegenerative diseases, visit munatherapeutics.com. #BrainDonationAwarenessDay #BetheBrain #Biotech

Thank you for this lovely post, Muna! I feel appreciated every day and am so grateful to support this incredible team 🥰

Today, we’re taking a moment to recognize and appreciate the incredible administrative professionals who keep our operations running smoothly. At Muna Therapeutics, we know that behind every breakthrough in neurodegenerative disease research, there's a dedicated team working tirelessly behind the scenes. From managing schedules to supporting research teams, Megan Roth and Susanne Bunkenborg Holbech of The Back Office in Copenhagen are invaluable to our mission of advancing treatments for diseases like Alzheimer’s and Parkinson’s. Thank you, Megan and Susanne, for your hard work, dedication, and for helping drive our shared vision of improved health outcomes! #AdministrativeProfessionalsDay #NeurologicalResearch #Biotech

Today, Muna Therapeutics celebrates Biomedical Research Awareness Day, to recognize the invaluable contributions of scientists, researchers, and innovators driving progress in treating diseases such as #Alzheimers and #Parkinsons. Muna’s commitment to advancing treatments for neurodegenerative diseases is powered by our passionate team and innovative MiND-MAP platform. This all-in-human target discovery and validation approach analyzes patient tissue samples to understand mechanisms underlying resilience to disease pathology. Through leveraging humanized animal models, human cells, patient tissue and biofluid samples, we assess the role of identified protein targets for the development of effective therapies for those living with neurodegenerative diseases. Learn more about our approach: munatherapeutics.com. #BRAD2025 #Biotech #BiomedicalResearch

Did you know that by 2050, an estimated 25.2 million people worldwide will be living with Parkinson's disease? These projections, representing a staggering 112% increase in global cases compared to 2021, highlight the urgent need for increased research, support, and awareness to address the growing impact of Parkinson's disease on individuals, families, and healthcare systems worldwide. Muna Therapeutics is proud to join the united effort to improve the lives of those affected by Parkinson's and support efforts to find better treatments and ultimately, a cure. Through our innovative MiND-MAP all-in-human target discovery approach, we are advancing understanding of how brain cells respond to pathological hallmarks of PD, with the goal of enhancing cell resilience.  Learn more about our approach at munatherapeutics.com. #ParkinsonsAwarenessMonth #NeurodegenerativeDiseases #Biotech #FightParkinsons